Larimar Therapeutics (LRMR) Retained Earnings (2013 - 2025)
Larimar Therapeutics (LRMR) posted Retained Earnings of $54000.0 for Q4 2025, up 100.01% on a QoQ basis from -$372.3 million in Q3 2025, and down 63.51% year-over-year from $148000.0 in Q4 2024.
Larimar Therapeutics (LRMR) Retained Earnings (2013 - 2025) Analysis & Trends
Larimar Therapeutics' Retained Earnings history runs 13 years deep, the most recent figure standing at $54000.0 for Q4 2025.
- Quarterly Retained Earnings fell 63.51% year-over-year to $54000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $54000.0 (down 63.51% YoY) and the FY2025 annual result came in at $54000.0, down 63.51% from the prior year.
- Retained Earnings was $54000.0 for Q4 2025 at Larimar Therapeutics, up from -$372.3 million in the prior quarter.
- Across five years, Retained Earnings topped out at $358000.0 in Q3 2024 and bottomed at -$372.3 million in Q3 2025.
- A 5-year average of -$121.5 million and a median of -$120.7 million in 2021 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2021 — Retained Earnings plunged 3010266.67% — and 2024, when it surged 5014.29%.
- Larimar Therapeutics' Retained Earnings stood at -$116.2 million in 2021, then jumped by 99.97% to -$31000.0 in 2022, then sank by 608138.71% to -$188.6 million in 2023, then soared by 100.08% to $148000.0 in 2024, then sank by 63.51% to $54000.0 in 2025.
- Business Quant data shows LRMR's Retained Earnings at $54000.0 in Q4 2025, -$372.3 million in Q3 2025, and -$324.6 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | -27.89 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -279.01 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 12.91 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -622,000.00 |
| 10 | Larimar Therapeutics | 37.00 Mn | -99.85 Mn | - | 54,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 54,000.00 |
| Sep 30, 2025 | -372.33 Mn |
| Jun 30, 2025 | -324.62 Mn |
| Mar 31, 2025 | 54,000.00 |
| Dec 31, 2024 | 148,000.00 |
| Sep 30, 2024 | 358,000.00 |
| Jun 30, 2024 | -224.80 Mn |
| Mar 31, 2024 | -203.20 Mn |
| Dec 31, 2023 | -188.55 Mn |
| Sep 30, 2023 | 7,000.00 |
| Jun 30, 2023 | -166.50 Mn |
| Mar 31, 2023 | -158.13 Mn |
| Dec 31, 2022 | -31,000.00 |
| Sep 30, 2022 | -142.20 Mn |
| Jun 30, 2022 | -133.86 Mn |
| Mar 31, 2022 | -125.20 Mn |
| Dec 31, 2021 | -116.25 Mn |
| Sep 30, 2021 | -107.12 Mn |
| Jun 30, 2021 | -90.31 Mn |
| Mar 31, 2021 | -77.70 Mn |